Suppliers / Aurobindo Pharma Limited, Unit - VIII

Aurobindo Pharma Limited, Unit - VIII

India Updated 9 July 2026

Aurobindo Pharma Limited, Unit - VIII is an API manufacturer based in India.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Amlodipine SFDA (Saudi Arabia) 1
Bosentan SFDA (Saudi Arabia) 1
Carvedilol SFDA (Saudi Arabia) 1
Dutasteride SFDA (Saudi Arabia) 1
Febuxostat SFDA (Saudi Arabia) 1
Fluconazole SFDA (Saudi Arabia) 1
Moxifloxacin SFDA (Saudi Arabia) 1
Palonosetron SFDA (Saudi Arabia) 1
Ramipril SFDA (Saudi Arabia) 1
Tamsulosin SFDA (Saudi Arabia) 1
Show all 11 molecules on file
Torasemide SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Dutasteride API Fluconazole API Palonosetron API Ramipril API Torasemide API Amlodipine API Tamsulosin API Carvedilol API Febuxostat API Moxifloxacin API Bosentan API

Questions about Aurobindo Pharma Limited, Unit - VIII

What does Aurobindo Pharma Limited, Unit - VIII make?
11 molecules are on record against Aurobindo Pharma Limited, Unit - VIII, including Amlodipine, Bosentan, Carvedilol and Dutasteride. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Aurobindo Pharma Limited, Unit - VIII comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 5 molecules Dr Reddy's Laboratories shares 4 molecules Hetero shares 3 molecules Cipla shares 3 molecules MSN Laboratories shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability